Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on May 07, 2021 12:22am
209 Views
Post# 33150072

New, non-invasive COVID-19 test could help detect the virus

New, non-invasive COVID-19 test could help detect the virus New, non-invasive COVID-19 test could help detect the virus through a breath test
 
The days of uncomfortable COVID-19 tests via a nasal swab could soon be a thing of the past.
 
Developers worked to create new technology known as BlowFISH to detect the presence of the virus through directly testing respiratory droplets.
 
This latest concept was created through a partnership with Medivolve and Marvel Diagnostics with the goal of improving care for COVID-19 patients. The initial round of clinical testing just wrapped up for this simple, inexpensive, non-invasive exhaled breath testing technology.
 
It works by blowing into a whistle-like device to collect samples directly from the lungs. These are also the same droplets believed to be the means of transmission if you are infected with COVID-19.
 
“You’re going to see who the superspreaders are or who potentially might be spreading the virus more than others,” Medivolve CEO David Preiner said.
 
Preiner believes the new technology could be a viable substitute for the traditional nasal swab COVID-19 test and could be used in drive-through testing or within schools.
 
“It makes it very easy to gather samples on a routine basis with no fear of it’s going to hurt,” Preiner explained. 
 
And even as the effects of the pandemic become less prominent, Preiner said COVID-19 testing will still have to be a priority.
 
“Staying on top of testing even in areas that are asymptomatic I think is critical because the goal is you want to catch a flare-up the moment it pops up,” Preiner said. 
 
The next step following the clinical trials is for BlowFISH to apply for emergency authorization use in hopes of getting FDA approval.
 
Contact Briana Harper at bharper@wcnc.com and follow her on FacebookTwitter and Instagram.
 
https://www.msn.com/en-us/health/medical/new-non-invasive-covid-19-test-could-help-detect-the-virus-through-a-breath-test/ar-BB1grAnb


User image

<< Previous
Bullboard Posts
Next >>